Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Motor Activity 20Polycystic Ovary Syndrome 10Prostatic Neoplasms 7Breast Neoplasms 6Neoplasms 5Colorectal Neoplasms 4Insulin Resistance 3Lung Neoplasms 2Fatigue 2Esophageal Neoplasms 2Cardiotoxicity 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Primary Dysautonomias 1Pediatric Brain Tumor 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Follicular 1Lupus Erythematosus, Systemic 1Inflammation 1Hodgkin Disease 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Disease 1Diabetes Mellitus, Type 1 1Chemotherapy-Related Cognitive Impairment 1Cardiovascular Diseases 1

Interventions

Cyclophosphamide 87fludarabine 77fludarabine phosphate 45Tacrolimus 45Whole-Body Irradiation 42Mycophenolic Acid 42Busulfan 35Melphalan 32Antilymphocyte Serum 24Methotrexate 23thymoglobulin 22Standard of Care 22Rituximab 22venetoclax 20Thiotepa 20Sirolimus 20Azacitidine 20Stem Cell Transplantation 18Granulocyte Colony-Stimulating Factor 18Practice Guidelines as Topic 17Cytarabine 16Bortezomib 16Nivolumab 15Filgrastim 15Specimen Handling 14Dexamethasone 14Blood Specimen Collection 14Cyclosporine 13Surveys and Questionnaires 12Mesna 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × High-Intensity Interval Training × Clear all
NCT03823651 2024-09-27

A Research Program Targeting Pre- and Peri-transplant Optimization Program (R-PPOP)

Duke University

Phase NA Completed
29 enrolled 14 charts
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡